Artios Pharma

Artios Pharma Limited is a company based in Cambridge, United Kingdom (Wikidata Q140045444, which also gives its website). ClinicalTrials.gov classes it as an industry sponsor. It leads two phase 1/2a trials recorded in OnCo: NCT04657068, the ATR kinase inhibitor ART0380 alone and in combination (with gemcitabine, irinotecan or FOLFIRI) in advanced or metastatic solid tumours including ovarian, endometrial, colorectal and pancreatic cancer, and NCT05898399 (POLKA), the DNA polymerase theta inhibitor ART6043 alone and with olaparib in advanced solid tumours. Both compounds are its own, which is the basis for the biotech type.